Logo
x

Search

Subscribe Now

Cardiovascular

Bayer Acquires Asklepios for ~$4B

Bayer Acquires Asklepios for ~$4B

  • October 26, 2020
Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

  • October 5, 2020
Takeda Divests its Select Non-Core Assets in the EU and Canada to Cheplapharm for $562M

Takeda Divests its Select Non-Core Assets in the EU and Canada to Cheplapharm for $562M

  • September 9, 2020
Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

  • September 8, 2020
AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

  • August 24, 2020
Eli Lilly Reports Dosing of its First Patient with Tirzepatide in P-III SURPASS-CVOT Study for Cardiovascular Outcomes

Eli Lilly Reports Dosing of its First Patient with Tirzepatide in P-III SURPASS-CVOT Study for Cardiovascular Outcomes

  • June 9, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.